Retatrutide Injection UK: Formats, Schedules and Handling
A retatrutide injection is supplied in the UK as a pre filled pen holding the compound in solution, ready to dial and deliver without reconstitution. This page covers what is actually in one, the formats and prices available, the schedules used in the published trials, and how the pen format compares with powder and vials. Retatrutide holds no UK marketing authorisation and everything here is supplied for laboratory research use only.
Research pens and kits in stock
Retatrutide
Retatrutide
Weight Loss
Weight Loss
Recovery
Recovery
Cosmetic
Cosmetic
Table of Contents
Retatrutide Injection Formats and Prices
| Format | Price | Cost per mg | Best for |
|---|---|---|---|
| 20mg pen | £139.99 | £7.00 | First order, shorter work |
| 40mg kit | £220 | £5.50 | Best value, extended work |
| 10mg pen (not stocked) | £80 to £110 elsewhere | £8.00 to £11.00 | Poor value, avoid |
What a Retatrutide Injection Contains
A retatrutide injection contains retatrutide, also written LY3437943, dissolved in a sterile aqueous solution with buffering agents to hold pH stable. It is supplied ready to use rather than as a powder requiring reconstitution, which removes the largest single source of measurement error in peptide work.
The compound itself is a synthetic peptide agonist. Background on what it is and where the name came from is in our reta peptide guide.
Why It Is Called a Triple Agonist
Retatrutide acts at three receptors at once: GLP-1, GIP and glucagon. Semaglutide targets the first alone and tirzepatide targets the first two, so the glucagon component is the addition unique to this compound.
The practical significance is that GLP-1 and GIP activity reduces energy intake while glucagon receptor activity raises energy expenditure, addressing both sides of the equation in one molecule. Our comparison guide works through what the trial data shows for each generation.
Injection Schedules From the Published Trials
Every published schedule used a weekly retatrutide injection reached through stepped escalation rather than started at the target amount.
| Weekly amount | Weeks from a 20mg pen | Weeks from a 40mg kit |
|---|---|---|
| 1mg | 20 | 40 |
| 2mg | 10 | 20 |
| 4mg | 5 | 10 |
| 8mg | 2.5 | 5 |
| 12mg | 1.67 | 3.3 |
The Phase 2 obesity study used target amounts of 1mg, 4mg, 8mg and 12mg weekly. Escalation is part of the protocol rather than an optional preamble, because the reported tolerability belongs to the stepped schedule and not to the endpoint amount reached by any other route. Complete schedules are in our dosage chart.
Pen Devices Against Vials and Reconstitution
Most research peptides are sold as lyophilised powder in vials requiring reconstitution with bacteriostatic water. A retatrutide injection pen ships pre filled instead, and the trade between formats is worth understanding rather than assuming one is simply better.
| Factor | Pre filled pen | Powder and vial |
|---|---|---|
| Reconstitution error | None | Largest source of variance |
| Storage stability | Solution clock starts at fill | Dry state far more stable |
| Dose reproducibility | High, dial metered | Depends on technique |
| Extra materials needed | Needles only | Bacteriostatic water, syringes, needles |
Handling Accuracy and Priming
Prime the device exactly as its instructions specify before the first delivery. An unprimed pen delivers less than the dial indicates, and that error carries through every subsequent measurement rather than being confined to one draw.
- Confirm the dial increment matches the smallest amount your protocol requires, since a coarse device cannot be made fine.
- Prime before first use and record the volume discarded.
- Use a fresh needle for every draw to avoid contaminating the cartridge.
- Record what was delivered rather than what was dialled.
- Exclude any figure taken from an unprimed first delivery.
Device mechanics across formats are compared in our retatrutide pen guide.
Storage Between Injections
- Refrigerate between 2 and 8 degrees and never freeze, since freezing denatures the peptide as reliably as heat does.
- Keep the pen in its original carton away from direct light.
- Store away from the refrigerator door where cycling is worst.
- Avoid repeated temperature excursions, which accumulate across a pen used over weeks.
- Log the batch number and any deviation on the day it happens.
The Price Floor Test
Synthesis, purification, sterile fill and refrigerated logistics impose a hard cost floor on any genuine retatrutide injection. Divide the asking price by the stated milligrams: anything below roughly £3 per milligram sits under that floor, and the usual explanations are underfill, a substituted cheaper peptide, or no active compound at all.
The MHRA seized roughly 20 million doses of illegal weight loss medicines in 2025, which indicates the scale of the counterfeit supply this test protects against. Full market figures are in our price index.
Compare formats and kits
Retatrutide
Retatrutide
Weight Loss
Weight Loss
Recovery
Recovery
Cosmetic
Cosmetic
Choosing a Retatrutide Injection Format
For a first order the 20mg pen at £139.99 is the sensible choice, since it verifies a supplier on a smaller commitment. For extended work the 40mg kit at £220 is better value at £5.50 per milligram and halves the cold chain exposure by requiring one delivery instead of two. We do not stock the 10mg format at all, and the reasoning is in our retatrutide 10mg guide.
Supplier checks worth running before any order are in our buy retatrutide UK guide, and everything in stock is on the shop page.
Why Injection Site Rotation Appears in Every Protocol
Every published protocol using a weekly retatrutide injection specifies rotating the delivery site rather than using the same location repeatedly. The reason is local tissue response: repeated delivery into one site alters the local tissue over time, and altered tissue absorbs differently from fresh tissue.
That creates a measurement problem rather than only a comfort problem. If absorption at a site changes across a study, the delivered amount stops being comparable week to week even though the dialled amount is identical. Rotation is therefore a data quality control, which is why it is specified rather than suggested.
Five Things That Go Wrong With Injection Protocols
These recur constantly in questions we receive, and every one of them distorts results rather than merely wasting material.
- Skipping the prime. The first delivery from an unprimed pen is short, and if that figure enters the record everything derived from it is wrong.
- Recording the dial rather than the delivery. The two differ whenever priming is incomplete or a needle is partly blocked.
- Reusing needles. This contaminates a cartridge intended to last weeks and risks losing the whole unit rather than one draw.
- Escalating faster than the published schedule. The reported tolerability data belongs to the stepped escalation, so a compressed schedule is an unstudied protocol rather than a faster version of a studied one.
- Assuming a warm parcel recovered. Refrigerating material after a transit excursion does not reverse the degradation that already occurred.
None of these are exotic failures. They are the ordinary ones, and they are why a contemporaneous log matters more than any single handling rule.
Recording a Retatrutide Injection Course
A record made at the time is worth more than a reconstruction afterwards. For each pen, capture the batch number as printed on the device, the arrival date and packaging condition, the storage location and its measured temperature range, the priming performed and volume discarded, then each delivery with its date and site.
Background literature on peptide stability and handling is indexed on PubMed, which is a better foundation for protocol design than any supplier summary including this one.
Legal Position in the United Kingdom
Retatrutide holds no marketing authorisation from the MHRA. It is not a licensed medicine in the United Kingdom, cannot lawfully be supplied for human use, and cannot be advertised with therapeutic claims under Advertising Standards Authority rules. Every retatrutide injection we supply is for laboratory research use only and is not for human or veterinary consumption.
Published trial evidence comes from pharmaceutical grade material administered under supervision to a screened population, and does not transfer to research material used outside that setting. Anyone seeking treatment should speak to a registered UK prescriber about licensed options. Nothing on this page is medical advice.
Retatrutide Injection FAQ
What is in a retatrutide injection?
Retatrutide, also written LY3437943, dissolved in sterile aqueous solution with buffering agents. It ships ready to use rather than as a powder requiring reconstitution.
How much does a retatrutide injection cost in the UK?
£139.99 for a 20mg pen, which is £7.00 per milligram, or £220 for a 40mg kit at £5.50 per milligram.
How often was retatrutide injected in the trials?
Weekly, with the amount escalated in steps rather than started at target. Published target amounts were 1mg, 4mg, 8mg and 12mg weekly.
Is a pen better than a vial?
A pen removes reconstitution error, which is the largest source of measurement variance. A powder vial is more stable in storage. For work spanning weeks the pen usually nets out ahead.
Why is a cheap retatrutide injection a warning sign?
Production and refrigerated handling impose a hard cost floor. Below roughly £3 per milligram the usual explanations are underfill, substitution, or no active compound.
Is retatrutide injection legal in the UK?
It may be supplied for laboratory research use only. It holds no MHRA authorisation and cannot lawfully be sold or supplied for human use.
